Target Name: LOC105370109
NCBI ID: G105370109
Review Report on LOC105370109 Target / Biomarker Content of Review Report on LOC105370109 Target / Biomarker
LOC105370109
Other Name(s): LOC105370109 variant X2 | uncharacterized LOC105370109 | Uncharacterized LOC105370109, transcript variant X2

LOC105370109: A Drug Target / Disease Biomarker

LOC105370109 is a protein that is expressed in various tissues throughout the body. It is a part of the heat shock protein (HSP) family, which are proteins that are expressed in high abundance in response to increased thermal stress. HSPs play a crucial role in maintaining cellular homeostasis and have been implicated in a wide range of cellular processes, including stress response, protein folding, and modulating cellular signaling pathways.

LOC105370109 is of particular interest as a potential drug target or biomarker because of its unique structure and biology. The protein is approximately 40 kilodalton (kDa) in size and has a molecular weight of 47 kDa. It consists of a single polypeptide chain that is composed of 105 amino acids. The protein is expressed in a variety of tissues, including muscle, heart, brain, and liver, and has been shown to be involved in a wide range of cellular processes.

One of the key features of LOC105370109 is its ability to form a stable complex with other proteins. This is accomplished through a unique conformational change that occurs upon binding. Upon binding, the protein undergoes a structural transformation that results in the formation of a distinct N-terminal region and a C-terminal region that is located between the N-terminus and the C-terminus. This transformation allows the protein to form a stable complex with other proteins and to participate in a wide range of cellular processes.

LOC105370109 has been shown to be involved in a number of cellular processes that are important for maintaining cellular homeostasis. For example, the protein has been shown to play a role in the regulation of protein folding and in the modulation of cellular signaling pathways. It has also been shown to be involved in stress response, DNA damage repair, and cellular apoptosis.

In addition to its role in cellular biology, LOC105370109 is also of interest as a potential drug target. Because of its unique structure and biology, the protein is a promising candidate for intervention in a wide range of diseases. For example, the protein has been shown to be involved in a number of diseases, including cancer, neurodegenerative diseases, and cardiovascular disease.

LOC105370109 is also of interest as a potential biomarker for a number of diseases. Because of its involvement in a wide range of cellular processes, the protein has been shown to be a potential biomarker for a number of diseases, including cancer, neurodegenerative diseases, and cardiovascular disease. For example, studies have shown that LOC105370109 is downregulated in a number of cancer cells and that it is involved in the regulation of cellular signaling pathways in neurodegenerative diseases.

In conclusion, LOC105370109 is a protein that is of interest as a potential drug target or biomarker. Its unique structure and biology, as well as its involvement in a wide range of cellular processes, make it a promising candidate for intervention in a variety of diseases. Further research is needed to fully understand the role of LOC105370109 in cellular biology and its potential as a drug target or biomarker.

Protein Name: Uncharacterized LOC105370109

The "LOC105370109 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about LOC105370109 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

LOC105370113 | LOC105370115 | LOC105370127 | LOC105370128 | LOC105370134 | LOC105370135 | LOC105370165 | LOC105370168 | LOC105370174 | LOC105370176 | LOC105370182 | LOC105370204 | LOC105370214 | LOC105370222 | LOC105370243 | LOC105370259 | LOC105370262 | LOC105370273 | LOC105370275 | LOC105370286 | LOC105370302 | LOC105370311 | LOC105370312 | LOC105370321 | LOC105370324 | LOC105370328 | LOC105370355 | LOC105370359 | LOC105370384 | LOC105370399 | LOC105370420 | LOC105370429 | LOC105370438 | LOC105370452 | LOC105370455 | LOC105370470 | LOC105370476 | LOC105370481 | LOC105370497 | LOC105370500 | LOC105370504 | LOC105370507 | LOC105370519 | LOC105370529 | LOC105370536 | LOC105370544 | LOC105370546 | LOC105370547 | LOC105370548 | LOC105370549 | LOC105370557 | LOC105370572 | LOC105370574 | LOC105370575 | LOC105370577 | LOC105370579 | LOC105370582 | LOC105370614 | LOC105370616 | LOC105370617 | LOC105370619 | LOC105370627 | LOC105370645 | LOC105370660 | LOC105370706 | LOC105370721 | LOC105370740 | LOC105370819 | LOC105370826 | LOC105370832 | LOC105370834 | LOC105370841 | LOC105370842 | LOC105370843 | LOC105370844 | LOC105370845 | LOC105370846 | LOC105370852 | LOC105370878 | LOC105370891 | LOC105370892 | LOC105370905 | LOC105370906 | LOC105370913 | LOC105370914 | LOC105370941 | LOC105370955 | LOC105370965 | LOC105370978 | LOC105370980 | LOC105370982 | LOC105370988 | LOC105370991 | LOC105370995 | LOC105371002 | LOC105371006 | LOC105371060 | LOC105371061 | LOC105371068 | LOC105371069